Overview

Gabapentin in Patients at Clinical Risk for Psychosis

Status:
Suspended
Trial end date:
2022-05-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the effects of the drug gabapentin on brain function thought to be important in the development of schizophrenia. Researchers think that treating a brain region with gabapentin (the hippocampus) may reduce the risk for developing schizophrenia.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
New York State Psychiatric Institute
Treatments:
Gabapentin
gamma-Aminobutyric Acid